APA (7th ed.) Citation

M, T., M, P., H, D., N, H., K, I., S, T., & CB, S. (2023). Co-administration of an effector antibody enhances the half-life and therapeutic potential of RNA-encoded nanobodies. Scientific reports, 13(1), 14632. https://doi.org/10.1038/s41598-023-41092-7

Chicago Style (17th ed.) Citation

M, Thran, Pönisch M, Danz H, Horscroft N, Ichtchenko K, Tzipori S, and Shoemaker CB. "Co-administration of an Effector Antibody Enhances the Half-life and Therapeutic Potential of RNA-encoded Nanobodies." Scientific Reports 13, no. 1 (2023): 14632. https://doi.org/10.1038/s41598-023-41092-7.

MLA (9th ed.) Citation

M, Thran, et al. "Co-administration of an Effector Antibody Enhances the Half-life and Therapeutic Potential of RNA-encoded Nanobodies." Scientific Reports, vol. 13, no. 1, 2023, p. 14632, https://doi.org/10.1038/s41598-023-41092-7.